Hot Papers

T. Braun, M.A. Rudnicki, H.H. Arnold, R. Jaenisch, "Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death," Cell, 71:369-82, 1992. M.A. Rudnicki, T. Braun, S. Hinuma, R. Jaenisch, "Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development," Cell, 71:383-90, 1992. M.A. Rudnicki, P.N.J. Schnegelab

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

T. Braun, M.A. Rudnicki, H.H. Arnold, R. Jaenisch, "Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death," Cell, 71:369-82, 1992.

M.A. Rudnicki, T. Braun, S. Hinuma, R. Jaenisch, "Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development," Cell, 71:383-90, 1992.

M.A. Rudnicki, P.N.J. Schnegelaberg, R.H. Stead, T. Braun, H.H. Arnold, R. Jaenisch, "MyoD or Myf-5 is required for the formation of skeletal muscle," Cell, 75:1351-9, 1993.

Michael A. Rudnicki (Institute for Molecular Biology and Biotechnology, McMaster University, Hamilton, Ontario, Canada): "Gene targeting has allowed the genetic dissection of the roles played by the myogenic regulatory factors (MRFs) in the development of skeletal muscle. The introduction of null [loss-of-function] mutations in Myf-5, MyoD, and myogenin into the germline of mice has revealed insights into the hierarchical relationships existing among the MRFs and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies